Publication | Open Access

Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing’s sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity

OncologyReverse Chemomodulatory EffectsSirt1 Activators ResveratrolChemoprevention StrategyMedicineCancer Cell BiologyAnti-cancer AgentTumor SuppressorCancer TreatmentRadiation OncologyCancer BiologyCell BiologyCancer ResearchTumor BiologyResveratrol Suppresses